Table 3.
Baseline Demographic Characteristics for All Subjects Receiving Study Treatment (Safety Evaluation Set, N = 154)
| Etermis 3 (N = 102) | Etermis 4 (N = 138) | Total (N = 154) |
|
|---|---|---|---|
| Sex (n (%)) | |||
| Male | 100 (98.0) | 134 (97.1) | 150 (97.4) |
| Female | 2 (2.0) | 4 (2.9) | 4 (2.6) |
| Age [years] | |||
| Mean (SD) | 51.7 (9.8) | 53.4 (9.3) | 52.3 (9.8) |
| Race (n (%)) | |||
| White | 101 (99.0) | 137 (99.3) | 153 (99.4) |
| Black | 1 (1.0) | 1 (0.7) | 1 (0.6) |
| Fitzpatrick Skin Type (n (%)) | |||
| I | 1 (1.0) | 2 (1.4) | 2 (1.3) |
| II | 47 (46.5) | 69 (50.0) | 81 (52.9) |
| III | 49 (48.5) | 62 (44.9) | 65 (42.5) |
| IV | 3 (3.0) | 4 (2.9) | 4 (2.6) |
| V | 1 (1.0) | 1 (0.7) | 1 (0.7) |
| Missing | 1 | 0 | 1 |
| BMI [kg/m2] | |||
| Mean (SD) | 23.42 (3.83) | 23.79 (4.14) | 23.58 (4.11) |
Abbreviations: SD, standard deviation; n, number of observations; N, number of subjects in corresponding group.